🔗 Permalink

Inventor profile of:

Daniel William DEMONTE

City:

Seattle, Washington

Country:

United States

Published Applications:

Last publication date:

2026-03-05

Top Assignees for applications by Daniel William DEMONTE

The entities that hold a legal rights for patent applications filed by inventor DEMONTE Daniel William:

ALPINE IMMUNE SCIENCES, INC. 22 Seattle, WA United States

Recent patent applications by DEMONTE Daniel William

Daniel William DEMONTE from Seattle, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-03-05

US20260062456A1

Chemistry; metallurgy

PD-L1 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF

#2 | 2025-07-31

US20250243260A1

Chemistry; metallurgy

IMMUNOMODULATORY PROTEINS OF VARIANT CD80 POLYPEPTIDES, CELL THERAPIES AND RELATED METHODS AND USES

#3 | 2025-01-16

US20250019413A1

Chemistry; metallurgy

APRIL AND BAFF INHIBITORY IMMUNOMODULATORY PROTEINS AND METHODS OF USE THEREOF

#4 | 2025-01-16

US20250019412A1

Chemistry; metallurgy

APRIL AND BAFF INHIBITORY IMMUNOMODULATORY PROTEINS AND METHODS OF USE THEREOF

#5 | 2024-12-05

US20240400643A1

Chemistry; metallurgy

April and BAFF inhibitory immunomodulatory proteins and methods of use thereof

#6 | 2024-10-31

US20240360197A1

Chemistry; metallurgy

PD-1 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF

#7 | 2024-07-04

US20240218045A1

Chemistry; metallurgy

APRIL AND BAFF INHIBITORY IMMUNOMODULATORY PROTEINS AND METHODS OF USE THEREOF

#8 | 2024-01-04

US20240002466A1

Chemistry; metallurgy

CD80 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF

#9 | 2023-11-30

US20230381229A1

Human necessities

CD155 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF

#10 | 2023-08-03

US20230241168A1

Human necessities

APRIL AND BAFF INHIBITORY IMMUNOMODULATORY PROTEINS WITH AND WITHOUT A T CELL INHIBITORY PROTEIN AND METHODS OF USE THEREOF

#11 | 2023-07-13

US20230220039A1

Chemistry; metallurgy

PD-L1 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF

#12 | 2021-12-16

US20210388054A1

Chemistry; metallurgy

APRIL and BAFF inhibitory immunomodulatory proteins and methods of use thereof

#13 | 2021-11-25

US20210363223A1

Chemistry; metallurgy

APRIL and BAFF inhibitory immunomodulatory proteins and methods of use thereof

#14 | 2021-11-25

US20210363219A1

Chemistry; metallurgy

PD-1 variant immunomodulatory proteins and uses thereof

#15 | 2021-08-19

US20210253668A1

Chemistry; metallurgy

CD112 variant immunomodulatory proteins and uses thereof

#16 | 2021-06-24

US20210188942A1

Chemistry; metallurgy

CD80 variant immunomodulatory proteins and uses thereof

#17 | 2021-06-10

US20210171603A1

Chemistry; metallurgy

CD80 variant immunomodulatory proteins and uses thereof

#18 | 2021-06-03

US20210163571A1

Chemistry; metallurgy

CD80 variant immunomodulatory proteins and uses thereof

#19 | 2021-05-27

US20210155669A1

Chemistry; metallurgy

CD80 variant immunomodulatory proteins and uses thereof

#20 | 2021-05-27

US20210155668A1

Chemistry; metallurgy

CD80 variant immunomodulatory proteins and uses thereof

#21 | 2021-05-06

US20210130437A1

Chemistry; metallurgy

PD-L2 variant immunomodulatory proteins and uses thereof

#22 | 2021-05-06

US20210130436A1

Chemistry; metallurgy

CD80 variant immunomodulatory proteins and uses thereof

#23 | 2019-06-13

US20190175654A1

Human necessities

CD155 variant immunomodulatory proteins and uses thereof

InventorID:

2525722 ⎘